TxGNN improves drug repurposing by predicting treatments for rare diseases with no approved therapies

A new model, TxGNN, revolutionizes zero-shot drug repurposing by predicting treatments for diseases with no known therapies, offering improved accuracy and trust via interpretable AI explanations.

Plants of the Spirit Realm: A Guide to Plants Containing DMT

Throughout history, various plants have been revered for their psychoactive properties, offering humans a gateway to altered states of consciousness and spiritual experiences. Dimethyltryptamine (DMT)

August 1, 2023

Metsera partners with Amneal to manufacture obesity drugs, and Clive Meanwell hands over CEO role

Obesity startup Metsera is getting a new manufacturing partner and a new CEO. On Tuesday, the well-funded startup announced that it would bring on specialty

October 2, 2024

Diabetes fuels antibiotic resistance, worsening infections and treatment challenges

A new study reveals that diabetes significantly accelerates the emergence and spread of antibiotic-resistant Staphylococcus aureus infections, highlighting a major public health concern.

February 17, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.